Physician

Anjum Tanwir, M.D.

According to 2025 Medicare claims, Anjum Tanwir, M.D. (NPI: 1144320128) practices cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is COMPREHENSIVE CARDIOVASCULAR CONSULTANTS OF NJ (NPI: 1558994566; TIN: 831881655) and primary practice location at 07083-6634. Tanwir is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Tanwir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,345 traditional Medicare patients, billed 9,231 HCPCS/CPT codes, and received $4,613,337 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 3,396 prescription claims across 497 beneficiaries totaling $634,563 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 129 claims. Open Payments data shows 27 records totaling $914. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $362,639 to $4,613,337. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $172,750 to $634,563. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,609 to $6,534.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	937	3,702	$362,639
2016	894	4,112	$387,840
2017	832	3,719	$353,501
2018	713	3,133	$299,934
2019	729	4,171	$431,955
2020	684	4,371	$608,764
2021	728	5,108	$1,668,172
2022	741	4,515	$1,614,848
2023	994	6,062	$2,619,224
2024	1,345	9,231	$4,613,337

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	286	2,423	$172,750
2016	289	2,367	$182,036
2017	289	2,426	$204,124
2018	343	2,596	$280,176
2019	504	3,793	$389,503
2020	535	5,041	$518,350
2021	555	5,065	$561,141
2022	563	4,281	$593,215
2023	497	3,403	$617,269
2024	497	3,396	$634,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	69	$2,988
2016	N/R	14	$450
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	51	$3,714
2020	N/R	15	$224
2021	N/R	129	$6,829
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	309	323	$160
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	509	704	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	380	820	$102
93925	Ultrasound of leg arteries or artery grafts	630	730	$78
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	302	409	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	319	17,200	$323,011
Entresto	Sacubitril/Valsartan	109	4,448	$95,960
Xarelto	Rivaroxaban	70	4,450	$79,083
Repatha Sureclick	Evolocumab	29	2,314	$44,117
Brilinta	Ticagrelor	15	930	$13,031

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$914	ShockWave Medical, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anjum Tanwir, M.D.?

Tedicare shows public-source Medicare data for Anjum Tanwir, M.D. (NPI 1144320128), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anjum Tanwir, M.D. have ACO affiliation data?

Anjum Tanwir, M.D. is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Anjum Tanwir, M.D.?

Anjum Tanwir, M.D. is linked to COMPREHENSIVE CARDIOVASCULAR CONSULTANTS OF NJ (billing NPI 1558994566) in the available physician profile data.

Does Anjum Tanwir, M.D. have Open Payments data?

Anjum Tanwir, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.